Literature DB >> 18542000

Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions.

Peter G Arthur1, Miranda D Grounds, Thea Shavlakadze.   

Abstract

PURPOSE OF REVIEW: The aim of this overview is to highlight the multiple ways in which oxidative stress could be exacerbating muscle wasting. Understanding these interactions in vivo will assist in identifying opportunities for more targeted therapies to reduce skeletal muscle wasting. RECENT
FINDINGS: There are many excellent reviews describing how oxidative stress can damage cellular macromolecules, as well as cause deleterious effects through the modulation of signalling pathways. In this overview, we highlight the potential for complex and possibly paradoxical interactions in vivo. Signalling pathways are discussed, using examples involving nuclear factor-kappa B, apoptosis signal-regulating kinase 1 and Akt. Oxidative stress may also be involved in complex interactions with other factors capable of stimulating the loss of muscle mass, possibly through amplifying feedback cycles. This is discussed using examples related to calcium and tumour necrosis factor.
SUMMARY: There is convincing evidence that oxidative stress can increase protein catabolism. The challenge is to demonstrate that oxidative stress is a significant player in the complex interplay that leads to the in-vivo muscle wasting that is caused by a range of conditions and diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18542000     DOI: 10.1097/MCO.0b013e328302f3fe

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  37 in total

1.  IGF-1 gene-modified muscle-derived stem cells are resistant to oxidative stress via enhanced activation of IGF-1R/PI3K/AKT signaling and secretion of VEGF.

Authors:  Chunjing Chen; Ying Xu; Yanfeng Song
Journal:  Mol Cell Biochem       Date:  2013-10-15       Impact factor: 3.396

2.  Sarcopenia and frailty: new challenges for clinical practice.

Authors:  Richard Dodds; Avan Aihie Sayer
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

3.  Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Elaine W Patterson; Jeffrey D Smith; Anne S Wilson; Zaheen Rabbani; Michael B Reid
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

Review 4.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

Review 5.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

6.  Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase.

Authors:  Anna Cozzoli; Antonella Liantonio; Elena Conte; Maria Cannone; Ada Maria Massari; Arcangela Giustino; Antonia Scaramuzzi; Sabata Pierno; Paola Mantuano; Roberta Francesca Capogrosso; Giulia Maria Camerino; Annamaria De Luca
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-30       Impact factor: 4.249

7.  Use of pifithrin to inhibit p53-mediated signalling of TNF in dystrophic muscles of mdx mice.

Authors:  Felicity J Waters; Thea Shavlakadze; Matthew J McIldowie; Matthew J Piggott; Miranda D Grounds
Journal:  Mol Cell Biochem       Date:  2009-10-27       Impact factor: 3.396

8.  Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Gavin J Pinniger; Jessica R Terrill; Evanna B Assan; Miranda D Grounds; Peter G Arthur
Journal:  J Physiol       Date:  2017-09-30       Impact factor: 5.182

9.  (-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle.

Authors:  Israel Ramirez-Sanchez; Sergio De los Santos; Silvia Gonzalez-Basurto; Patricia Canto; Patricia Mendoza-Lorenzo; Carlos Palma-Flores; Guillermo Ceballos-Reyes; Francisco Villarreal; Alejandro Zentella-Dehesa; Ramon Coral-Vazquez
Journal:  FEBS J       Date:  2014-10-30       Impact factor: 5.542

10.  Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure.

Authors:  Hamit Yasar Ellidag; Esin Eren; Necat Yılmaz; Yesim Cekin
Journal:  Redox Rep       Date:  2014-01-13       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.